PARDRIDGE WILLIAM M has a total of 14 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ARMAGEN TECHNOLOGIES INC, TEVA PHARMACEUTICALS AUSTRALIA PTY LTD and ROCHE GLYCART AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Machines | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Unspecified technologies | |
#7 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Pardridge William M | 14 |
#2 | Boado Ruben J | 13 |
Publication | Filing date | Title |
---|---|---|
US2011110935A1 | Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS | |
US2010261647A1 | Fusion proteins for delivery of erythropoietin to the CNS | |
US2010098693A1 | Compositions and methods for blood-brain barrier delivery of organophosphatases | |
US2010077498A1 | Compositions and methods for blood-brain barrier delivery in the mouse | |
US2009156498A1 | Fusion proteins for delivery of GDNF to the CNS | |
US2007081992A1 | Fusion proteins for blood-brain barrier delivery | |
US4992255A | Capillary depletion method for quantifying transcytosis through the blood-brain barrier |